174 related articles for article (PubMed ID: 34105220)
41. Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus.
Mercorelli B; Oreste P; Sinigalia E; Muratore G; Lembo D; Palù G; Loregian A
Antimicrob Agents Chemother; 2010 Nov; 54(11):4561-7. PubMed ID: 20713657
[TBL] [Abstract][Full Text] [Related]
42. Comparison of Metal-Ammine Compounds Binding to DNA and Heparin. Glycans as Ligands in Bioinorganic Chemistry.
Katner SJ; Johnson WE; Peterson EJ; Page P; Farrell NP
Inorg Chem; 2018 Mar; 57(6):3116-3125. PubMed ID: 29473748
[TBL] [Abstract][Full Text] [Related]
43. Identification of novel nucleotide phosphonate analogs with potent anti-HCMV activity.
Nguyen-Ba P; Turcotte N; Yuen L; Bédard J; Quimpère M; Chan L
Bioorg Med Chem Lett; 1998 Dec; 8(24):3561-6. PubMed ID: 9934471
[TBL] [Abstract][Full Text] [Related]
44. Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors.
Marks RM; Lu H; Sundaresan R; Toida T; Suzuki A; Imanari T; Hernáiz MJ; Linhardt RJ
J Med Chem; 2001 Jun; 44(13):2178-87. PubMed ID: 11405655
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.
Maruyama T; Kozai S; Yamasaki T; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E
Antivir Chem Chemother; 2003 Sep; 14(5):271-9. PubMed ID: 14694990
[TBL] [Abstract][Full Text] [Related]
46. PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro.
Meyer AL; Bruening EE; Dunkle WE; Booth RJ; Steinbaugh BA; Vara Prasad JV
Antiviral Res; 2001 Dec; 52(3):289-300. PubMed ID: 11675146
[TBL] [Abstract][Full Text] [Related]
47. Decreased type VI collagen gene expression in cultured Werner's syndrome fibroblasts.
Hatamochi A; Mori K; Takeda K; Arakawa M; Ueki H; Yoshioka H
J Invest Dermatol; 1993 Jun; 100(6):771-4. PubMed ID: 8496616
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
Wang Y; Mao L; Kankanala J; Wang Z; Geraghty RJ
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881652
[TBL] [Abstract][Full Text] [Related]
49. Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB.
Townsend LB; Gudmundsson KS; Daluge SM; Chen JJ; Zhu Z; Koszalka GW; Boyd L; Chamberlain SD; Freeman GA; Biron KK; Drach JC
Nucleosides Nucleotides; 1999; 18(4-5):509-19. PubMed ID: 10432642
[TBL] [Abstract][Full Text] [Related]
50. Chemoenzymatic Synthesis of Glycosaminoglycans.
Zhang X; Lin L; Huang H; Linhardt RJ
Acc Chem Res; 2020 Feb; 53(2):335-346. PubMed ID: 31714740
[TBL] [Abstract][Full Text] [Related]
51. [Two cases of Werner's syndrome treated with penetrating keratoplasty].
Shintani M; Ikegami H; Kawaguchi Y; Hosotani H; Miki T; Ogihara T
Nihon Ronen Igakkai Zasshi; 1993 Jun; 30(6):503-5. PubMed ID: 8361067
[TBL] [Abstract][Full Text] [Related]
52. Autoradiographic studies of DNA replication in Werner's syndrome cells.
Hanaoka F; Yamada M; Takeuchi F; Goto M; Miyamoto T; Hori T
Adv Exp Med Biol; 1985; 190():439-57. PubMed ID: 4083159
[TBL] [Abstract][Full Text] [Related]
53. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
[TBL] [Abstract][Full Text] [Related]
54. A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis.
Barbosa I; Morin C; Garcia S; Duchesnay A; Oudghir M; Jenniskens G; Miao HQ; Guimond S; Carpentier G; Cebrian J; Caruelle JP; van Kuppevelt T; Turnbull J; Martelly I; Papy-Garcia D
J Cell Sci; 2005 Jan; 118(Pt 1):253-64. PubMed ID: 15615789
[TBL] [Abstract][Full Text] [Related]
55. Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus.
Zoepfl M; Dwivedi R; Taylor MC; Pomin VH; McVoy MA
Antiviral Res; 2021 Jun; 190():105077. PubMed ID: 33864843
[TBL] [Abstract][Full Text] [Related]
56. Interaction of human β-defensin 2 (HBD2) with glycosaminoglycans.
Seo ES; Blaum BS; Vargues T; De Cecco M; Deakin JA; Lyon M; Barran PE; Campopiano DJ; Uhrín D
Biochemistry; 2010 Dec; 49(49):10486-95. PubMed ID: 21062008
[TBL] [Abstract][Full Text] [Related]
57. Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins.
Beelontally R; Wilkie GS; Lau B; Goodmaker CJ; Ho CMK; Swanson CM; Deng X; Wang J; Gray NS; Davison AJ; Strang BL
Antiviral Res; 2017 Feb; 138():61-67. PubMed ID: 27956134
[TBL] [Abstract][Full Text] [Related]
58. Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation.
Morla S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013618
[TBL] [Abstract][Full Text] [Related]
59. Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity.
Hahn F; Hutterer C; Henry C; Hamilton ST; Strojan H; Kraut A; Schulte U; Schütz M; Kohrt S; Wangen C; Pfizer J; Couté Y; Rawlinson WD; Strobl S; Marschall M
Antiviral Res; 2018 Nov; 159():84-94. PubMed ID: 30268914
[TBL] [Abstract][Full Text] [Related]
60. An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.
Fujimoto KJ; Nema D; Ninomiya M; Koketsu M; Sadanari H; Takemoto M; Daikoku T; Murayama T
Antiviral Res; 2018 Jun; 154():10-16. PubMed ID: 29559264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
